Cyclosporin A corrects daunorubicin resistance in Ehrlich ascites carcinoma.

We have previously developed a daunorubicin resistant subline of Ehrlich ascites carcinoma (EA/DR) for studies on the reversal of daunorubicin resistance. The mean survival of untreated BALB/c mice bearing drug sensitive parental tumour (EA/DS) is 18.4 +/- 0.6 days, mice bearing EA/DS treated with f...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Slater, L. M., Sweet, P., Stupecky, M., Wetzel, M. W., Gupta, S.
Format: Artigo
Sprog:Inglês
Udgivet: Nature Publishing Group 1986
Fag:
Research Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2001522/
https://ncbi.nlm.nih.gov/pubmed/3741759
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker